Enhancement of the participant experience in quality of life (QOL) research is imperative to improve recruitment and ongoing engagement in QOL studies. Implementation of recommendations made by the patient and public involvement representatives for STAMPEDE2 could optimise the impact of QOL studies, with a benefit for participants and collection of invaluable data for cancer care research.
European urology oncology. 2024 Aug 20 [Epub ahead of print]
Minal Padden-Modi, Hannah Rush, Hoda Abdel-Aty, David Matheson, Robin Millman, Patrick Williams, Bertrand Tombal, Nicholas James
Institute of Cancer Research and Royal Marsden Hospital NHS Foundation Trust, London, UK; MRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK. Electronic address: ., MRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK. Electronic address: ., Institute of Cancer Research and Royal Marsden Hospital NHS Foundation Trust, London, UK; MRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK., MRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK; Health and Wellbeing, Faculty of Education, Wolverhampton University Walsall Campus, Walsall, UK., MRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK., Institut de Recherche Clinique, Université Catholique de Louvain, Louvain-la-Neuve, Belgium.
PubMed http://www.ncbi.nlm.nih.gov/pubmed/39168780